https:\/\/prtimes.jp\/main\/html\/rd\/p\/000000015.000079724.html<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"Mediplus Pharma, Inc. presented the safety and efficacy of its proprietary ingredient, ozonized glycerin (Novel Glycerin Compound), in formulations for atopic dermatitis at the 123rd Annual Meeting of the Japanese Dermatological Association. The conference was held from June 6 to June 9, 2024, at the Kyoto International Conference Center. For more details on the press release, please visit here.https:\/\/prtimes.jp\/main\/html\/rd\/p\/000000015.000079724.html<\/p>\n","protected":false},"author":1,"featured_media":3695,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[77,75],"tags":[],"class_list":["post-3689","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-conferencesexhibitions","category-newsroom-en"],"yoast_head":"\n
Presentation on the efficacy of Ozonized Glycerin (Novel Glycerin Compound) formulation for Atopic Dermatitis at the Japanese Dermatological Association - Mediplus Pharma, Inc.<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.mediplus-pharma.co.jp\/en\/presentation-on-the-efficacy-of-ozonized-glycerin-novel-glycerin-compound-formulation-for-atopic-dermatitis-at-the-japanese-dermatological-association\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Presentation on the efficacy of Ozonized Glycerin (Novel Glycerin Compound) formulation for Atopic Dermatitis at the Japanese Dermatological Association - Mediplus Pharma, Inc.\" \/>\n<meta property=\"og:description\" content=\"Mediplus Pharma, Inc. presented the safety and efficacy of its proprietary ingredient, ozonized glycerin (Novel Glycerin Compound), in formulations for atopic dermatitis at the 123rd Annual Meeting of the Japanese Dermatological Association. The conference was held from June 6 to June 9, 2024, at the Kyoto International Conference Center. For more details on the press release, please visit here.https:\/\/prtimes.jp\/main\/html\/rd\/p\/000000015.000079724.html\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.mediplus-pharma.co.jp\/en\/presentation-on-the-efficacy-of-ozonized-glycerin-novel-glycerin-compound-formulation-for-atopic-dermatitis-at-the-japanese-dermatological-association\/\" \/>\n<meta property=\"og:site_name\" content=\"Mediplus Pharma, Inc.\" \/>\n<meta property=\"article:published_time\" content=\"2024-07-04T02:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-21T02:57:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.mediplus-pharma.co.jp\/_wordpress\/wp-content\/uploads\/2024\/07\/de8742d9a963b6bf58aa1c2210191187.png\" \/>\n\t<meta property=\"og:image:width\" content=\"670\" \/>\n\t<meta property=\"og:image:height\" content=\"619\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Mediplus Pharma\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.mediplus-pharma.co.jp\/en\/presentation-on-the-efficacy-of-ozonized-glycerin-novel-glycerin-compound-formulation-for-atopic-dermatitis-at-the-japanese-dermatological-association\/\",\"url\":\"https:\/\/www.mediplus-pharma.co.jp\/en\/presentation-on-the-efficacy-of-ozonized-glycerin-novel-glycerin-compound-formulation-for-atopic-dermatitis-at-the-japanese-dermatological-association\/\",\"name\":\"Presentation on the efficacy of Ozonized Glycerin (Novel Glycerin Compound) formulation for Atopic Dermatitis at the Japanese Dermatological Association - Mediplus Pharma, Inc.\",\"isPartOf\":{\"@id\":\"https:\/\/www.mediplus-pharma.co.jp\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.mediplus-pharma.co.jp\/en\/presentation-on-the-efficacy-of-ozonized-glycerin-novel-glycerin-compound-formulation-for-atopic-dermatitis-at-the-japanese-dermatological-association\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.mediplus-pharma.co.jp\/en\/presentation-on-the-efficacy-of-ozonized-glycerin-novel-glycerin-compound-formulation-for-atopic-dermatitis-at-the-japanese-dermatological-association\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.mediplus-pharma.co.jp\/_wordpress\/wp-content\/uploads\/2024\/07\/de8742d9a963b6bf58aa1c2210191187.png\",\"datePublished\":\"2024-07-04T02:00:00+00:00\",\"dateModified\":\"2025-10-21T02:57:12+00:00\",\"author\":{\"@id\":\"https:\/\/www.mediplus-pharma.co.jp\/en\/#\/schema\/person\/6b64defb6ffc8a545a1aa0d1a36a5d9e\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.mediplus-pharma.co.jp\/en\/presentation-on-the-efficacy-of-ozonized-glycerin-novel-glycerin-compound-formulation-for-atopic-dermatitis-at-the-japanese-dermatological-association\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.mediplus-pharma.co.jp\/en\/presentation-on-the-efficacy-of-ozonized-glycerin-novel-glycerin-compound-formulation-for-atopic-dermatitis-at-the-japanese-dermatological-association\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.mediplus-pharma.co.jp\/en\/presentation-on-the-efficacy-of-ozonized-glycerin-novel-glycerin-compound-formulation-for-atopic-dermatitis-at-the-japanese-dermatological-association\/#primaryimage\",\"url\":\"https:\/\/www.mediplus-pharma.co.jp\/_wordpress\/wp-content\/uploads\/2024\/07\/de8742d9a963b6bf58aa1c2210191187.png\",\"contentUrl\":\"https:\/\/www.mediplus-pharma.co.jp\/_wordpress\/wp-content\/uploads\/2024\/07\/de8742d9a963b6bf58aa1c2210191187.png\",\"width\":670,\"height\":619},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.mediplus-pharma.co.jp\/en\/presentation-on-the-efficacy-of-ozonized-glycerin-novel-glycerin-compound-formulation-for-atopic-dermatitis-at-the-japanese-dermatological-association\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"\u30db\u30fc\u30e0\",\"item\":\"https:\/\/www.mediplus-pharma.co.jp\/en\/home\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Presentation on the efficacy of Ozonized Glycerin (Novel Glycerin Compound) formulation for Atopic Dermatitis at the Japanese Dermatological Association\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.mediplus-pharma.co.jp\/en\/#website\",\"url\":\"https:\/\/www.mediplus-pharma.co.jp\/en\/\",\"name\":\"Mediplus Pharma, Inc.\",\"description\":\"Passion for Sustainable Future By Novel Glycerin Compounds. Mediplus pharma, Inc.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.mediplus-pharma.co.jp\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.mediplus-pharma.co.jp\/en\/#\/schema\/person\/6b64defb6ffc8a545a1aa0d1a36a5d9e\",\"name\":\"Mediplus Pharma\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.mediplus-pharma.co.jp\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/f1f0541f736ea63a92287f69d757275b?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/f1f0541f736ea63a92287f69d757275b?s=96&d=mm&r=g\",\"caption\":\"Mediplus Pharma\"},\"sameAs\":[\"https:\/\/www.mediplus-pharma.co.jp\/_wordpress\"],\"url\":\"https:\/\/www.mediplus-pharma.co.jp\/en\/author\/mpp-admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Presentation on the efficacy of Ozonized Glycerin (Novel Glycerin Compound) formulation for Atopic Dermatitis at the Japanese Dermatological Association - Mediplus Pharma, Inc.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.mediplus-pharma.co.jp\/en\/presentation-on-the-efficacy-of-ozonized-glycerin-novel-glycerin-compound-formulation-for-atopic-dermatitis-at-the-japanese-dermatological-association\/","og_locale":"en_US","og_type":"article","og_title":"Presentation on the efficacy of Ozonized Glycerin (Novel Glycerin Compound) formulation for Atopic Dermatitis at the Japanese Dermatological Association - Mediplus Pharma, Inc.","og_description":"Mediplus Pharma, Inc. presented the safety and efficacy of its proprietary ingredient, ozonized glycerin (Novel Glycerin Compound), in formulations for atopic dermatitis at the 123rd Annual Meeting of the Japanese Dermatological Association. The conference was held from June 6 to June 9, 2024, at the Kyoto International Conference Center. For more details on the press release, please visit here.https:\/\/prtimes.jp\/main\/html\/rd\/p\/000000015.000079724.html","og_url":"https:\/\/www.mediplus-pharma.co.jp\/en\/presentation-on-the-efficacy-of-ozonized-glycerin-novel-glycerin-compound-formulation-for-atopic-dermatitis-at-the-japanese-dermatological-association\/","og_site_name":"Mediplus Pharma, Inc.","article_published_time":"2024-07-04T02:00:00+00:00","article_modified_time":"2025-10-21T02:57:12+00:00","og_image":[{"width":670,"height":619,"url":"https:\/\/www.mediplus-pharma.co.jp\/_wordpress\/wp-content\/uploads\/2024\/07\/de8742d9a963b6bf58aa1c2210191187.png","type":"image\/png"}],"author":"Mediplus Pharma","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.mediplus-pharma.co.jp\/en\/presentation-on-the-efficacy-of-ozonized-glycerin-novel-glycerin-compound-formulation-for-atopic-dermatitis-at-the-japanese-dermatological-association\/","url":"https:\/\/www.mediplus-pharma.co.jp\/en\/presentation-on-the-efficacy-of-ozonized-glycerin-novel-glycerin-compound-formulation-for-atopic-dermatitis-at-the-japanese-dermatological-association\/","name":"Presentation on the efficacy of Ozonized Glycerin (Novel Glycerin Compound) formulation for Atopic Dermatitis at the Japanese Dermatological Association - Mediplus Pharma, Inc.","isPartOf":{"@id":"https:\/\/www.mediplus-pharma.co.jp\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.mediplus-pharma.co.jp\/en\/presentation-on-the-efficacy-of-ozonized-glycerin-novel-glycerin-compound-formulation-for-atopic-dermatitis-at-the-japanese-dermatological-association\/#primaryimage"},"image":{"@id":"https:\/\/www.mediplus-pharma.co.jp\/en\/presentation-on-the-efficacy-of-ozonized-glycerin-novel-glycerin-compound-formulation-for-atopic-dermatitis-at-the-japanese-dermatological-association\/#primaryimage"},"thumbnailUrl":"https:\/\/www.mediplus-pharma.co.jp\/_wordpress\/wp-content\/uploads\/2024\/07\/de8742d9a963b6bf58aa1c2210191187.png","datePublished":"2024-07-04T02:00:00+00:00","dateModified":"2025-10-21T02:57:12+00:00","author":{"@id":"https:\/\/www.mediplus-pharma.co.jp\/en\/#\/schema\/person\/6b64defb6ffc8a545a1aa0d1a36a5d9e"},"breadcrumb":{"@id":"https:\/\/www.mediplus-pharma.co.jp\/en\/presentation-on-the-efficacy-of-ozonized-glycerin-novel-glycerin-compound-formulation-for-atopic-dermatitis-at-the-japanese-dermatological-association\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.mediplus-pharma.co.jp\/en\/presentation-on-the-efficacy-of-ozonized-glycerin-novel-glycerin-compound-formulation-for-atopic-dermatitis-at-the-japanese-dermatological-association\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.mediplus-pharma.co.jp\/en\/presentation-on-the-efficacy-of-ozonized-glycerin-novel-glycerin-compound-formulation-for-atopic-dermatitis-at-the-japanese-dermatological-association\/#primaryimage","url":"https:\/\/www.mediplus-pharma.co.jp\/_wordpress\/wp-content\/uploads\/2024\/07\/de8742d9a963b6bf58aa1c2210191187.png","contentUrl":"https:\/\/www.mediplus-pharma.co.jp\/_wordpress\/wp-content\/uploads\/2024\/07\/de8742d9a963b6bf58aa1c2210191187.png","width":670,"height":619},{"@type":"BreadcrumbList","@id":"https:\/\/www.mediplus-pharma.co.jp\/en\/presentation-on-the-efficacy-of-ozonized-glycerin-novel-glycerin-compound-formulation-for-atopic-dermatitis-at-the-japanese-dermatological-association\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"\u30db\u30fc\u30e0","item":"https:\/\/www.mediplus-pharma.co.jp\/en\/home\/"},{"@type":"ListItem","position":2,"name":"Presentation on the efficacy of Ozonized Glycerin (Novel Glycerin Compound) formulation for Atopic Dermatitis at the Japanese Dermatological Association"}]},{"@type":"WebSite","@id":"https:\/\/www.mediplus-pharma.co.jp\/en\/#website","url":"https:\/\/www.mediplus-pharma.co.jp\/en\/","name":"Mediplus Pharma, Inc.","description":"Passion for Sustainable Future By Novel Glycerin Compounds. Mediplus pharma, Inc.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.mediplus-pharma.co.jp\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.mediplus-pharma.co.jp\/en\/#\/schema\/person\/6b64defb6ffc8a545a1aa0d1a36a5d9e","name":"Mediplus Pharma","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.mediplus-pharma.co.jp\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/f1f0541f736ea63a92287f69d757275b?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f1f0541f736ea63a92287f69d757275b?s=96&d=mm&r=g","caption":"Mediplus Pharma"},"sameAs":["https:\/\/www.mediplus-pharma.co.jp\/_wordpress"],"url":"https:\/\/www.mediplus-pharma.co.jp\/en\/author\/mpp-admin\/"}]}},"_links":{"self":[{"href":"https:\/\/www.mediplus-pharma.co.jp\/en\/wp-json\/wp\/v2\/posts\/3689"}],"collection":[{"href":"https:\/\/www.mediplus-pharma.co.jp\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.mediplus-pharma.co.jp\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.mediplus-pharma.co.jp\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.mediplus-pharma.co.jp\/en\/wp-json\/wp\/v2\/comments?post=3689"}],"version-history":[{"count":4,"href":"https:\/\/www.mediplus-pharma.co.jp\/en\/wp-json\/wp\/v2\/posts\/3689\/revisions"}],"predecessor-version":[{"id":3697,"href":"https:\/\/www.mediplus-pharma.co.jp\/en\/wp-json\/wp\/v2\/posts\/3689\/revisions\/3697"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.mediplus-pharma.co.jp\/en\/wp-json\/wp\/v2\/media\/3695"}],"wp:attachment":[{"href":"https:\/\/www.mediplus-pharma.co.jp\/en\/wp-json\/wp\/v2\/media?parent=3689"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.mediplus-pharma.co.jp\/en\/wp-json\/wp\/v2\/categories?post=3689"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.mediplus-pharma.co.jp\/en\/wp-json\/wp\/v2\/tags?post=3689"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}